amlodipine has been researched along with Infarction, Middle Cerebral Artery in 5 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the effects of amlodipine, an L-type calcium channel blocker, on stroke size after focal brain ischemia in apolipoprotein E-deficient (ApoE KO) mice." | 7.73 | Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice. ( Chen, R; Horiuchi, M; Ide, A; Iwai, M; Iwanami, J; Mogi, M; Tsukuda, K; Yoshii, T, 2006) |
| " Treatment with azelnidipine and amlodipine reduced infarct volume and brain edema." | 3.74 | Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats. ( Abe, K; Deguchi, K; Hayashi, T; Kamiya, T; Lukic-Panin, V; Sehara, Y; Tsuchiya, A; Yamashita, T; Zhang, H, 2007) |
| "This study investigated the effects of amlodipine, an L-type calcium channel blocker, on stroke size after focal brain ischemia in apolipoprotein E-deficient (ApoE KO) mice." | 3.73 | Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice. ( Chen, R; Horiuchi, M; Ide, A; Iwai, M; Iwanami, J; Mogi, M; Tsukuda, K; Yoshii, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navia, V | 1 |
| Riveros, R | 1 |
| Brunser, A | 1 |
| Zhang, X | 1 |
| Deguchi, S | 1 |
| Deguchi, K | 2 |
| Ohta, Y | 1 |
| Yamashita, T | 2 |
| Shang, J | 1 |
| Tian, F | 1 |
| Liu, N | 1 |
| Liu, W | 1 |
| Ikeda, Y | 1 |
| Matsuura, T | 1 |
| Abe, K | 2 |
| Rafii, MS | 1 |
| Koenig, M | 1 |
| Ziai, WC | 1 |
| Mogi, M | 1 |
| Iwai, M | 1 |
| Chen, R | 1 |
| Iwanami, J | 1 |
| Ide, A | 1 |
| Tsukuda, K | 1 |
| Yoshii, T | 1 |
| Horiuchi, M | 1 |
| Lukic-Panin, V | 1 |
| Kamiya, T | 1 |
| Zhang, H | 1 |
| Hayashi, T | 1 |
| Tsuchiya, A | 1 |
| Sehara, Y | 1 |
5 other studies available for amlodipine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
[Intravenous thrombolysis after reversion of acenocoumarol anticoagulation. Report of one case].
Topics: Acenocoumarol; Administration, Intravenous; Aged, 80 and over; Amlodipine; Humans; Infarction, Middl | 2019 |
Amlodipine and atorvastatin exert protective and additive effects via antiapoptotic and antiautophagic mechanisms after transient middle cerebral artery occlusion in Zucker metabolic syndrome rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Apoptosis; Atorvastatin; Autophagy; Brain; Heptanoic A | 2011 |
Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke.
Topics: Acute Disease; Amlodipine; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Dexam | 2005 |
Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice.
Topics: Amlodipine; Animals; Apolipoproteins E; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Ci | 2006 |
Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
Topics: Amlodipine; Animals; Antioxidants; Apoptosis; Azetidinecarboxylic Acid; Brain; Brain Edema; Brain In | 2007 |